Rossetti, Andrea O; Milligan, Tracey A; Vulliémoz, Serge; Michaelides, Costas; Bertschi, Manuel; Lee, Jong Woo (2011). A randomized trial for the treatment of refractory status epilepticus. Neurocritical care, 14(1), pp. 4-10. New York, N.Y.: Springer 10.1007/s12028-010-9445-z
|
Text
s12028-010-9445-z.pdf - Published Version Available under License Publisher holds Copyright. Download (230kB) | Preview |
Refractory status epilepticus (RSE) has a mortality of 16-39%; coma induction is advocated for its management, but no comparative study has been performed. We aimed to assess the effectiveness (RSE control, adverse events) of the first course of propofol versus barbiturates in the treatment of RSE.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology |
UniBE Contributor: |
Bertschi, Manuel |
ISSN: |
1541-6933 |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:26 |
Last Modified: |
05 Dec 2022 14:07 |
Publisher DOI: |
10.1007/s12028-010-9445-z |
PubMed ID: |
20878265 |
Web of Science ID: |
000286394300002 |
BORIS DOI: |
10.48350/9458 |
URI: |
https://boris.unibe.ch/id/eprint/9458 (FactScience: 215195) |
Actions (login required)
 |
Edit item |